Territorial Availability: Available through Bertin Technologies only in France
- Correlated keywords
- antibodies receptors DNA gamma amino acids transcription factors ROR proteins ligands Fas IL2 RORA RORB tissues muscles lymph nodes cells RAR Nuclear Receptor RZR gamma Nuclear receptor RZR-gamma Nuclear Receptor RZR-gamma Nuclear receptor subfamily 1 group F member 1 Retinoid Related Orphan Receptor gamma Retinoid-related orphan receptor-gamma Retinoid-Related Orphan Receptor-gamma RZR gamma RZR-gamma, Nuclear Receptor nuclear receptor ROR-gamma retinoic acid receptor-related orphan receptor gamma RORgamma
- Product Overview:
ROR? is a 560 amino acid novel DNA-binding transcription factor belonging to the ROR/RZR orphan nuclear receptor subfamily. The specific functions of this protein are not known. However, reports suggest that this protein is a ligand activated transcription factor and may be essential for lymphoid organogenesis (lymph nodes and Peyer’s patches) and may play an important regulatory role in controlling apoptosis during thymopoiesis. ROR? inhibits the expression of Fas ligand and IL2 and directs the differentiation program of proinflammatory IL-17+ T helper cells. ROR-? shares 50 to 51% sequence identity with ROR? and ROR? and is 88% identical to mouse ROR?. It is highly expressed in skeletal muscle and at lower levels in various other tissues.
Cayman Chemical’s mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.
Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.
Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.
Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.
Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009
Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.